Willingness to Receive COVID-19 Vaccination Among Adult Diabetes Patients in Woldia Comprehensive Specialized Hospital, North Ethiopia; A Cross-Sectional Study

Abstract

Background According to recently published data, individuals infected with COVID-19 having concomitant diabetes may experience disease worsening or even death. The purpose of this study was to determine diabetes patients’ willingness to get the COVID-19 vaccine as well as its magnitude and determinants. Methods Three hundred eighty six diabetes patients who visited Woldia Comprehensive Specialized Hospital during February and March 2022 participated in this institution-based cross-sectional study. Descriptive statistics were used to demonstrate frequencies and percentages, while logistic regression was used to identify the relevant determinants of vaccination readiness. Age, gender, income, place of residence, COVID-19 exposure, length of diabetes, awareness of and attitudes toward the COVID-19 immunization were all evaluated as associated factors. Results Out of 386 study participants, 268 (69.43%) were male and 146 (37.82) completed their secondary schooling. From 386 study participants 82.6% (95% CI; 78.5–86.3%) were willing to get vaccinated. The uptake of the COVID-19 vaccination among diabetes patients was independently influenced by sex (Adjusted Odd Ratio [AOR] = 6.84 (2.98, 15.68)), exposure to the illness (AOR 8.98 (3.22, 25.04)), attitude (AOR = 2.63 (1.2, 5.77)), and length of the disease (AOR = 0.62 (0.51, 0.76)). Conclusion Most of the study participants were willing to get the COVID-19 immunization. The relevant agency should make the immunization available in order to enhance disease control and reduce infection-related complications with special consideration of diabetes patients.

COVID-19 vaccine acceptance and its association with knowledge and attitude among patients with chronic diseases in Ethiopia

“…26 The minimum and maximum sample sizes were from the Bahir Dar and Gondar studies, 280 and 423 respectively. 45 , 46 Of the 12 studies: seven from Amhara region, 24 , 28 , 41 , 45 , 46 , 48 three from Central Ethiopia (formerly part of the Southern nations, nationalities and peoples of Ethiopia region), 26 , 29 , 44 one from Oromia, 40 and one from Addis Ababa administrative region. 47 Furthermore, 75% of the studies included adult patients with chronic diseases, who had follow up at hospital.…”

“…‘Should you take or have you taken the COVID-19 vaccine?’ And (3.) ‘If a vaccine against COVID-19 is available, will you take it?.” 24 , 26 , 28 , 29 , 41 , 42 , 44–49 As a result, this review included all studies that used either of the above-mentioned definitions.…”

“…Therefore, the knowledge of the participants about the COVID-19 vaccine was measured through either of the following means 1 : Questions were asked and respondents who scored 70% or more were taken as having good knowledge. 24 , 28 , 43 , 45 , 46 , 48 Questions were asked and respondents who scored higher than the mean were considered to have good knowledge. 26 , 40 , 44 Therefore, this review included all studies that used either of the above-mentioned definitions.…”

“…Similarly, the attitude of the participants about the COVID-19 vaccine was measured 1 : Likert scale questionnaires were asked and the respondents scored 70% and above were taken as having favorable attitude. 24 , 28 , 43 , 45 , 48 Based on the mean score: respondents who scored higher than the mean were considered to have favorable attitude. 26 , 40 , 44 This review included articles based on at least one of the above measurements used by the primary studies.…”

Global acceptance of COVID-19 vaccine among persons with diabetes: A systematic review and meta-analysis

“…Apart from Osuagwu et al’s study which recruited participants from multiple countries in Sub-Saharan Africa, all the remaining studies involved a single country. Grouped under the continent of study, Asia dominated with 8 studies [6] , [9] , [20] , [21] , [22] , [23] , [24] , [25] , followed by North America (n = 5) [26] , [27] , [28] , [29] , [30] , Europe (n = 2) [7] , [31] , Africa (n = 2) [19] , [32] , and Australia (n = 1) [33] . A summary of the characteristics of the included studies is provided in Table 1 .…”